A Nomogram for Predicting Survival Rate of Digit Replantation after Traumatic Amputations: Development and Validation Based on a Prospective Multicenter Cohort

Tao Gao,Qianying Cai,Bingbo Bao,Maoyuan Tian,Lei Xia,Haifeng Wei,Hongyi Zhu,Xianyou Zheng
DOI: https://doi.org/10.2139/ssrn.4283765
2022-01-01
SSRN Electronic Journal
Abstract:Background: Success of digit replantation after traumatic amputation is difficult to predict. We aimed to develop a prognostic nomogram to better identify factors that better predict success rate after replantation following traumatic digit amputation.Methods: In this multicenter prospective cohort, we identified patients who had received digit replantation between January 1, 2015, and January 1, 2019. Univariable and multivariable analyses were performed successively to identify independently predictive factors for survival of replanted digit. To reduce overfitting, the Bayesian information criterion was used to reduce variables in the original model. Nomograms were created with the reduced model after model selection. The nomogram was then internally validated with bootstrap resampling and further externally validated in validation cohort.Results: Digit replantation was successful in 961 of 1062 (90.5%) digits and 1010 of 1156 digits (87.4%) in the training and validation cohorts, respectively. We found that six independent prognostic variables were associated with digit survival: age, mechanism of injury, ischemia duration, smoking status, amputation pattern (complete or incomplete), and surgeon’s experience. The nomogram achieved good discrimination, with concordance indexes of 0.81 (95% CI, 0.76-0.85) and 0.70 (95% CI, 0.65-0.74) in predicting digit survival in the training and validation cohorts, respectively. Calibration curves were well-fitted for both training and validation cohorts.Interpretation: The proposed nomogram effectively predicted the success rate of digit replantation for individual digits of all patients. It could assist in selecting the most suitable surgical plan for the patient.Trial registration: Chinese Clinical Trial Registry Identifier: ChiCTR1900026268Funding: This study was supported by National Natural Science Foundation of China (Grant 82002324, Hongyi Zhu; Grant 81974331,Xianyou Zheng); Clinical Technology Innovation Project of Shanghai Hospital Development Center (Grant SHDC12019X06, Xianyou Zheng); the Clinical Research Project of Shanghai Municipal Health Commission (Grant 20194Y0254, Hongyi Zhu)Declaration of Interest: NoneEthical Approval: This study was approved by the ethics committees of Shanghai Jiaotong University Affiliated Sixth People’s Hospital, Xi’an Honghui Hospital, and 80 PLA Hospital.
What problem does this paper attempt to address?